LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being approved for the common mental health condition ...

San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...

The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe generalized anxiety ...

Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 ...

Kia America today announced pricing for the upcoming all-new 2027 Kia Telluride 3-row SUV (ICE). With seating for up to 8 ...

Massachusetts approves on-site cannabis consumption at licensed businesses, including yoga studios and theaters. New social ...

LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

Speaker Mike Johnson lobbied Trump directly to hold off on his decision, the Washington Post reported. On the eve of Trump’s ...

Definium’s late-stage pipeline includes four Phase 3 trials—two each for GAD and MDD—anchored by its lead candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD.